OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 15 citing articles:

Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular Targeting
Minakshi Saikia, N.W. Cheung, Abhay K. Singh, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8739-8739
Open Access | Times Cited: 22

Multiomic analysis uncovers a continuous spectrum of differentiation and Wnt-MDK-driven immune evasion in hepatoblastoma
Daniel Münter, Flavia W. de Faria, Mathis Richter, et al.
Journal of Hepatology (2025)
Open Access | Times Cited: 1

Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies
Hui Ma, Qing-Zhu Yan, Jingru Ma, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 10, pp. 1295-1312
Open Access | Times Cited: 6

The NF1+/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation
Emily E. White, Steven D. Rhodes
Cancers (2024) Vol. 16, Iss. 5, pp. 994-994
Open Access | Times Cited: 5

Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma
Josephine G. M. Strijker, Guillem Pascual‐Pasto, Grant Grothusen, et al.
European Journal of Cancer (2025), pp. 115263-115263
Open Access

The role of midkine in health and disease
Emely Elisa Neumaier, Veit Rothhammer, Mathias Linnerbauer
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12

Targeting TIME in Advanced Hepatocellular Carcinoma: Mechanisms of Drug Resistance and Treatment Strategies
Xinyi Ye, Xizhu Fang, Fangfang Li, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104735-104735
Closed Access

Target immune components to circumvent sorafenib resistance in hepatocellular carcinoma
Shuhua Wei, Fenghua Wei, Mengyuan Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114798-114798
Open Access | Times Cited: 10

PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma
Xiaoyu Liu, Man Liu, Haoran Wu, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101087-101087
Open Access | Times Cited: 3

Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions
Qianming Kang, Luying He, Yang Zhang, et al.
Phytomedicine (2024) Vol. 130, pp. 155684-155684
Closed Access | Times Cited: 2

Midkine promotes tumor growth and attenuates the effect of cisplatin in small cell lung cancer
Shotaro Ito, Jun Sakakibara‐Konishi, Mineyoshi Sato, et al.
Research Square (Research Square) (2024)
Open Access

RNA Interference based Midkine Gene Therapy for Hepatocellular Carcinoma
Samah Mamdouh, Fatma Khorshed, Gehan Hammad, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 7, pp. 2371-2379
Open Access

Nasopharynx Battlefield: Cellular Immune Responses Mediated by Midkine in Nasopharyngeal Carcinoma and COVID-19
Ngar‐Woon Kam, Cho-Yiu Lau, Chi‐Ming Che, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4850-4850
Open Access | Times Cited: 1

Page 1

Scroll to top